2024-519835-41-00招募中4 期
A study to compare the absorption of two tablet strengths with the absorption of a solution.
Arvinas Operations Inc.1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2025年2月27日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 18
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trials NS
Scientific
Arvinas Operations Inc.
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A study of the safety, absorption and effects of investigational drug ARV-102 in patients with Parkinson's disease.2024-516888-84-00Arvinas Operations Inc.44
已完成
1 期
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood2023-506367-33-00Boehringer Ingelheim International GmbH16
已完成
1 期
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid TumorsCancer2022-503080-15-00Kadmon Corporation LLC30
已完成
1 期
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants with Renal Impairment2024-514359-14-00AstraZeneca AB32
已完成
1 期
A Drug Absorption Study of MK-3475A in Participants with Solid Tumors2023-505340-19-00Merck Sharp & Dohme LLC34